Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03038867Phase 2Completed
A Phase 2 trial of duloxetine in major depressive disorder (MDD), sponsored by Weill Cornell Medicine. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03038867.